lin inhibitor, showing potent activity against paclitaxel sensitive and resistant prostate cancer models, will be presented in a session at the 2018 European Association of Urology (EAU) 33rd Annual Congress to be held March 16-20, 2018, at the Bella Center in Copenhagen, Denmark. Chemotherapy prolongs survival and improves th